These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 8109466)
1. [Interaction between a prostaglandin F2 alpha derivative, UF-021, and pilocarpine in ocular hypotensive therapy]. Yamamoto T; Chi Q; Kitazawa Y Nippon Ganka Gakkai Zasshi; 1994 Feb; 98(2):202-5. PubMed ID: 8109466 [TBL] [Abstract][Full Text] [Related]
2. [Prospects of using latanoprost, prostaglandin F2 alpha analog, in hypotensive therapy for glaucoma]. Egorov EA; Nesterov AP; Romanova OV Vestn Oftalmol; 1998; 114(4):19-20. PubMed ID: 9771080 [TBL] [Abstract][Full Text] [Related]
3. Effect of changing from concomitant timolol pilocarpine to bimatoprost monotherapy on ocular blood flow and IOP in primary chronic angle closure glaucoma. Agarwal HC; Gupta V; Sihota R J Ocul Pharmacol Ther; 2003 Apr; 19(2):105-12. PubMed ID: 12804055 [TBL] [Abstract][Full Text] [Related]
4. Interaction of pilocarpine with latanoprost in patients with glaucoma and ocular hypertension. Kent AR; Vroman DT; Thomas TJ; Hebert RL; Crosson CE J Glaucoma; 1999 Aug; 8(4):257-62. PubMed ID: 10464735 [TBL] [Abstract][Full Text] [Related]
5. [Clinical evaluation of UF-021 ophthalmic solution in glaucoma patients refractory to maximum tolerable therapy]. Azuma I Nippon Ganka Gakkai Zasshi; 1993 Feb; 97(2):232-8. PubMed ID: 8475836 [TBL] [Abstract][Full Text] [Related]
6. Double-masked comparative study of UF-021 and timolol ophthalmic solutions in patients with primary open-angle glaucoma or ocular hypertension. Azuma I; Masuda K; Kitazawa Y; Takase M; Yamamura H Jpn J Ophthalmol; 1993; 37(4):514-25. PubMed ID: 8145398 [TBL] [Abstract][Full Text] [Related]
7. Intraocular pressure-lowering effects of latanoprost monotherapy versus latanoprost or pilocarpine in combination with timolol: a randomized, observer-masked multicenter study in patients with open-angle glaucoma. Italian Latanoprost Study Group. Bucci MG J Glaucoma; 1999 Feb; 8(1):24-30. PubMed ID: 10084271 [TBL] [Abstract][Full Text] [Related]
8. [Effect on pressure after instillation of a drop of depot-pilocarpine. Clinical results of its medium-term action]. Andermann C; Mialhe D; Arne JL; Vende D; Bec P J Fr Ophtalmol; 1983; 6(4):367-74. PubMed ID: 6350412 [TBL] [Abstract][Full Text] [Related]
9. Ocular hypotensive effect of PhXA41 in patients with ocular hypertension or primary open-angle glaucoma. Hotehama Y; Mishima HK; Kitazawa Y; Masuda K Jpn J Ophthalmol; 1993; 37(3):270-4. PubMed ID: 8295364 [TBL] [Abstract][Full Text] [Related]
10. A comparison of the efficacy of various metipranolol-pilocarpine combinations in patients with ocular hypertension and primary open-angle glaucoma. Sharir M; Zimmerman TJ; del Negro RG; Ball SF; Kooner KS J Ocul Pharmacol; 1994; 10(2):411-20. PubMed ID: 7916025 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of latanoprost versus pilocarpine/timolol maleate fixed combination in patients with primary open-angle glaucoma or ocular hypertension. Kałuzny J; Sobecki R; Czechowicz-Janicka K; Kecik D; Kałuzny BJ; Stewart JA; Stewart WC Acta Ophthalmol; 2008 Dec; 86(8):860-5. PubMed ID: 18721251 [TBL] [Abstract][Full Text] [Related]
12. Ocular hypotensive effects and safety over 3 months of switching from an unfixed combination to latanoprost 0.005%/timolol maleate 0.5% fixed combination. Inoue K; Okayama R; Higa R; Sawada H; Wakakura M; Tomita G J Ocul Pharmacol Ther; 2011 Dec; 27(6):581-7. PubMed ID: 22011049 [TBL] [Abstract][Full Text] [Related]
13. Ocular hypotensive efficacy and safety of a combined formulation of betaxolol and pilocarpine. Robin AL Trans Am Ophthalmol Soc; 1996; 94():89-101; discussion 101-3. PubMed ID: 8981691 [TBL] [Abstract][Full Text] [Related]
14. Comparative study of aqueous and oily pilocarpine in the production of ocular hypotension. Bhojwani SC; Jones DK Br J Ophthalmol; 1981 Aug; 65(8):530-2. PubMed ID: 7295614 [TBL] [Abstract][Full Text] [Related]
15. [Ocular effects of topical instillation of UF-021 ophthalmic solution in healthy volunteers]. Takase M; Murao M; Koyano S; Okita M; Ueno R Nippon Ganka Gakkai Zasshi; 1992 Oct; 96(10):1261-7. PubMed ID: 1442350 [TBL] [Abstract][Full Text] [Related]
16. [Ocular hypotensive effect of 1% carteolol long-acting eye drops--a double-masked, randomized phase III study in ocular hypertension or primary open-angle glaucoma patients comparing long-acting carteolol eye drops vs. current product]. Yamamoto T; Nippon Ganka Gakkai Zasshi; 2007 Jun; 111(6):463-72. PubMed ID: 17601060 [TBL] [Abstract][Full Text] [Related]
18. [Proxodolol, a new domestic preparation for lowering intraocular pressure in glaucoma]. Ermakova VN; Iuzhakov SD; Mashkovskiĭ MD; Kolomoĭtseva EM Vestn Oftalmol; 1995; 111(2):4-7. PubMed ID: 7645180 [TBL] [Abstract][Full Text] [Related]
19. [Clinical observation on the effect of 4% pilocarpine gel used one dose per day in the treatment of glaucoma]. Yie T; Liang L; Chen X Yan Ke Xue Bao; 2000 Jun; 16(2):77-80. PubMed ID: 12579908 [TBL] [Abstract][Full Text] [Related]
20. A prospective, long-term, randomized study of the efficacy and safety of the drug combination pilocarpine 1% with clonidine 0.06% or clonidine 0.125% versus timolol 0.25%. Sihota R; Rajashekhar YL; Venkatesh P; Agarwal H J Ocul Pharmacol Ther; 2002 Dec; 18(6):499-506. PubMed ID: 12537676 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]